Latest & greatest articles for fibromyalgia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on fibromyalgia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on fibromyalgia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for fibromyalgia

81. Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. (PubMed)

Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. 21178598 2011 04 08 2011 08 04 2013 11 21 1536-5409 27 4 2011 May The Clinical journal of pain Clin J Pain Effect of intravenous lidocaine associated with amitriptyline on pain relief and plasma serotonin, norepinephrine, and dopamine concentrations in fibromyalgia. 285-8 10.1097/AJP.0b013e3181ffbfde The objective of this study (...) and norepinephrine levels were similar in the 2 groups at T0 and T4. An increase in dopamine levels was observed in monotherapy group from the beginning to the end of treatment. Combined administration of 240 mg intravenous lidocaine (once a week) and 25 mg amitriptyline for 4 weeks did not modify pain intensity or plasma serotonin, norepinephrine, or dopamine concentrations in fibromyalgia patients. Vlainich Roberto R Department of Anesthesiology, Universidade Federal de São Paulo, Rua Tres de Maio 61, São

2011 EvidenceUpdates

82. Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia (PubMed)

Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia 21146466 2011 07 13 2015 11 19 1528-8447 12 4 2011 Apr The journal of pain : official journal of the American Pain Society J Pain Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia. 407-15 10.1016/j.jpain.2010.09.007 Fibromyalgia is a difficult-to-treat chronic pain syndrome that affects 2% of the US population. Pregabalin is an antiepileptic recently FDA approved (...) for fibromyalgia treatment. Other antiepileptics have been suggested for treatment. This systematic review examines the relative benefits and harms of antiepileptic drugs in the treatment of fibromyalgia. A literature search was conducted and 8 studies matched criteria (7 studies of pregabalin, 1 of gabapentin). Both drugs reduced mean pain scores more than placebo at a modest rate (pregabalin, 38% to 50%; gabapentin, 51%). In a 6-month trial of pregabalin responders, 32% continued to have response at 6 months

2011 EvidenceUpdates

83. Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trial (PubMed)

Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized, placebo-controlled trial 21078629 2011 02 22 2012 02 21 2013 11 21 1462-0332 50 3 2011 Mar Rheumatology (Oxford, England) Rheumatology (Oxford) Hormonal replacement therapy does not affect self-estimated pain or experimental pain responses in post-menopausal women suffering from fibromyalgia: a double-blind, randomized (...) NCT01087593 Journal Article Randomized Controlled Trial 2010 11 14 England Rheumatology (Oxford) 100883501 1462-0324 0 Estrogens 4TI98Z838E Estradiol AIM IM Administration, Cutaneous Double-Blind Method Estradiol administration & dosage Estrogen Replacement Therapy Estrogens administration & dosage Female Fibromyalgia drug therapy physiopathology Humans Middle Aged Pain diagnosis drug therapy Pain Measurement Pain Threshold Postmenopause 2010 11 17 6 0 2010 11 17 6 0 2012 2 22 6 0 ppublish 21078629 keq348

Full Text available with Trip Pro

2011 EvidenceUpdates

84. Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis (PubMed)

Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis 21078630 2012 02 21 2015 11 19 1462-0332 50 3 2011 Mar Rheumatology (Oxford, England) Rheumatology (Oxford) Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. 532-43 10.1093/rheumatology/keq354 To evaluate and compare the efficacy and acceptability (...) Antidepressive Agents therapeutic use Cyclopropanes therapeutic use Duloxetine Hydrochloride Fibromyalgia drug therapy Humans Thiophenes therapeutic use Treatment Outcome 2010 11 17 6 0 2010 11 17 6 0 2012 2 22 6 0 ppublish 21078630 keq354 10.1093/rheumatology/keq354

Full Text available with Trip Pro

2011 EvidenceUpdates

85. Treating fibromyalgia with mindfulness-based stress reduction: results from a 3-armed randomized controlled trial (PubMed)

Treating fibromyalgia with mindfulness-based stress reduction: results from a 3-armed randomized controlled trial 21146930 2011 01 17 2011 12 07 2011 01 17 1872-6623 152 2 2011 Feb Pain Pain Treating fibromyalgia with mindfulness-based stress reduction: results from a 3-armed randomized controlled trial. 361-9 10.1016/j.pain.2010.10.043 Mindfulness-based stress reduction (MBSR) is a structured 8-week group program teaching mindfulness meditation and mindful yoga exercises. MBSR aims to help (...) participants develop nonjudgmental awareness of moment-to-moment experience. Fibromyalgia is a clinical syndrome with chronic pain, fatigue, and insomnia as major symptoms. Efficacy of MBSR for enhanced well-being of fibromyalgia patients was investigated in a 3-armed trial, which was a follow-up to an earlier quasi-randomized investigation. A total of 177 female patients were randomized to one of the following: (1) MBSR, (2) an active control procedure controlling for nonspecific effects of MBSR, or (3

2011 EvidenceUpdates

86. Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine (PubMed)

Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine 20598442 2010 12 20 2011 04 14 2015 11 19 1872-6623 152 1 2011 Jan Pain Pain Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. 31-7 10.1016/j.pain.2010.05.029 The objective of this paper (...) is to better understand the relationship of pain and mood in patients with fibromyalgia and comorbid major depressive disorder (MDD). Pooled data from 4 double-blind, placebo-controlled, randomized trials of duloxetine hydrochloride 60-120mg/day in patients with fibromyalgia were included (N=1332). Of these, 350 (26% [147 placebo, 203 duloxetine]) had comorbid MDD (per Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Text Revision criteria) and were included in these analyses. Primary

2011 EvidenceUpdates

87. Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial (PubMed)

Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial 21112423 2010 11 29 2011 01 11 2015 11 19 1532-821X 91 12 2010 Dec Archives of physical medicine and rehabilitation Arch Phys Med Rehabil Aerobic exercise versus combined exercise therapy in women with fibromyalgia syndrome: a randomized controlled trial. 1838-43 10.1016/j.apmr.2010.09.006 To investigate the effects of supervised aerobic exercise (AE) and a combined program (...) of supervised aerobic, muscle strengthening, and flexibility exercises (combined exercise [CE]) on important health outcomes in women with fibromyalgia syndrome (FMS). Randomized controlled trial. Community-based supervised intervention. Women (N=64) with a diagnosis of FMS according to the American College of Rheumatology criteria. Participants were randomly allocated to 1 of 3 groups: supervised AE, supervised CE, or usual-care control. Exercise sessions were performed twice weekly (45-60min/session

2011 EvidenceUpdates

88. Internet-enhanced management of fibromyalgia: a randomized controlled trial (PubMed)

Internet-enhanced management of fibromyalgia: a randomized controlled trial 20855168 2010 11 03 2011 02 11 2016 11 22 1872-6623 151 3 2010 Dec Pain Pain Internet-enhanced management of fibromyalgia: a randomized controlled trial. 694-702 10.1016/j.pain.2010.08.034 Both pharmacological and non-pharmacological interventions have demonstrated efficacy in the management of fibromyalgia (FM). Non-pharmacological interventions however are far less likely to be used in clinical settings, in part due (...) . 2009 Nov;146(1-2):205-13 19695776 Ann Rheum Dis. 2009 Dec;68(12):1800-4 19910301 Curr Rheumatol Rep. 2009 Dec;11(6):443-50 19922735 Ann Behav Med. 2009 Aug;38(1):18-27 19802647 Ann Behav Med. 2009 Aug;38(1):28-39 19806416 Ann Behav Med. 2009 Aug;38(1):40-5 19834778 Arthritis Rheum. 2008 Jul 15;59(7):952-60 18576290 Behavior Therapy Exercise Therapy Fibromyalgia psychology therapy Humans Internet Self Care Severity of Illness Index Surveys and Questionnaires Telemedicine Treatment Outcome

Full Text available with Trip Pro

2011 EvidenceUpdates

89. A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalgia (PubMed)

A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalgia 20946990 2010 10 15 2011 02 14 2016 10 25 1872-6623 151 2 2010 Nov Pain Pain A pilot randomized controlled trial of the Yoga of Awareness program in the management of fibromyalgia. 530-9 10.1016/j.pain.2010.08.020 A mounting body of literature recommends that treatment for fibromyalgia (FM) encompass medications, exercise and improvement of coping skills. However, there is a significant gap (...) of Anesthesiology and Peri-operative Medicine, Oregon Health & Science University, Portland, OR 97239-3011, USA. carsonja@ohsu.edu Carson Kimberly M KM Jones Kim D KD Bennett Robert M RM Wright Cheryl L CL Mist Scott D SD eng K23 AT006392 AT NCCIH NIH HHS United States Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't United States Pain 7508686 0304-3959 IM Adult Aged Awareness physiology Catastrophization etiology Fatigue etiology Female Fibromyalgia complications psychology

Full Text available with Trip Pro

2011 EvidenceUpdates

90. Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia

Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia Systematic review of the comparative effectiveness of antiepileptic drugs for fibromyalgia Chamberlin Siler A, Gardner H, Yanit K, Cushman T, McDonagh M CRD summary This review concluded that the anti-epileptics pregabalin and gabapentin were moderately effective for treatment of fibromyalgia but that their long (...) -term safety and efficacy were unknown. Despite some concerns about the synthesis, the authors' conclusions are probably reliable. Authors' objectives To assess the comparative benefits and harms of different anti-epileptic drugs for the treatment of fibromyalgia. Searching MEDLINE, DARE and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from 1996 to 2009. Documents from the Food and Drug Administration website and references from identified studies and reviews were also

2011 DARE.

91. Psychological treatments for fibromyalgia: a meta-analysis. (PubMed)

Psychological treatments for fibromyalgia: a meta-analysis. 20727679 2010 10 15 2011 02 14 2011 05 10 1872-6623 151 2 2010 Nov Pain Pain Psychological treatments for fibromyalgia: a meta-analysis. 280-95 10.1016/j.pain.2010.06.011 The aims of the present analysis were to investigate the short- and long-term efficacies and treatment moderators of psychological interventions for fibromyalgia. A literature search using PubMed, PsychINFO, the Cochrane Library, and manual searches identified 23 (...) analyses demonstrated that the effect sizes were robust. The results suggest that the effects of psychological treatments for fibromyalgia are relatively small but robust and comparable to those reported for other pain and drug treatments used for this disorder. Cognitive-behavioral therapy was associated with the greatest effect sizes. Copyright © 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved. Glombiewski Julia A JA Department of Psychology

2011 EvidenceUpdates

92. Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia (PubMed)

Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia 20521308 2010 10 08 2010 10 26 2011 12 09 2151-4658 62 10 2010 Oct Arthritis care & research Arthritis Care Res (Hoboken) Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. 1377-85 10.1002/acr.20268 The treatment of patients with fibromyalgia (FM), a high-prevalence chronic pain condition with a high impact on both patients and society, poses (...) Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't United States Arthritis Care Res (Hoboken) 101518086 2151-464X IM Arthritis Care Res (Hoboken). 2011 Jun;63(6):921-2; author reply 922-4 21360694 Ann Intern Med. 2011 Apr 19;154(8):JC4-8 21502646 Adult Cognitive Therapy methods Exercise Therapy methods Female Fibromyalgia psychology therapy Follow-Up Studies Humans Male Middle Aged Pain Measurement classification methods Risk Factors 2010 6 4 6 0 2010 6 4 6 0 2010 10 27 6 0

Full Text available with Trip Pro

2010 EvidenceUpdates

93. Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial (PubMed)

Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial 20532650 2010 09 21 2011 08 16 2016 12 15 1525-1497 25 10 2010 Oct Journal of general internal medicine J Gen Intern Med Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial. 1064-70 10.1007/s11606-010-1418-6 Affect and how it is regulated plays a role in pain perception, maintenance of pain, and its resolution. This randomized, controlled (...) trial evaluated an innovative affective self-awareness (ASA) intervention, which was designed to reduce pain and improve functioning in individuals with fibromyalgia. Forty-five women with fibromyalgia were randomized to a manualized ASA intervention (n = 24) or wait-list control (n = 21). The intervention began with a one-time physician consultation, followed by 3 weekly, 2-h group sessions based upon a mind-body model of pain. Sessions focused on structured written emotional disclosure

Full Text available with Trip Pro

2010 EvidenceUpdates

94. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials (PubMed)

Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials 20682676 2011 02 14 2010 10 04 0315-162X 37 10 2010 Oct The Journal of rheumatology J. Rheumatol. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome - a systematic review and metaanalysis of randomized controlled trials. 1991-2005 10.3899/jrheum.100104 We performed the first systematic review with metaanalysis of the efficacy of cognitive (...) -behavioral therapies (CBT) in fibromyalgia syndrome (FM). We screened Cochrane Library, Medline, PsychINFO, and Scopus (through June 2009) and the reference sections of original studies and systematic reviews for CBT in FM. Randomized controlled trials (RCT) comparing CBT to controls were analyzed. Primary outcomes were pain, sleep, fatigue, and health-related quality of life (HRQOL). Secondary outcomes were depressed mood, self-efficacy pain, and healthcare-seeking behavior. Effects were summarized

2010 EvidenceUpdates

95. Pain response profile of patients with fibromyalgia treated with duloxetine (PubMed)

Pain response profile of patients with fibromyalgia treated with duloxetine 20551724 2010 06 16 2010 09 22 2015 11 19 1536-5409 26 6 2010 Jul-Aug The Clinical journal of pain Clin J Pain Pain response profile of patients with fibromyalgia treated with duloxetine. 498-504 10.1097/AJP.0b013e3181dee80e This study examined the time course for minimal clinically significant improvement in pain severity during the initial 12 weeks of treatment in patients with fibromyalgia taking duloxetine. Four (...) %, respectively. This article examines the time course for minimal clinically significant improvement in pain severity in duloxetine-treated patients with fibromyalgia. It provides information about continued treatment in patients who do not initially respond to duloxetine. This information could potentially help physicians facing clinical decisions about management of fibromyalgia with duloxetine. Bradley Laurence A LA University of Alabama at Birmingham, Birmingham, AL, USA. Wohlreich Madelaine M MM Wang

2010 EvidenceUpdates

96. Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review (PubMed)

Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review 20202927 2011 03 11 2013 11 21 1462-0332 49 6 2010 Jun Rheumatology (Oxford, England) Rheumatology (Oxford) Evidence for the efficacy of complementary and alternative medicines in the management of fibromyalgia: a systematic review. 1063-8 10.1093/rheumatology/keq025 To critically evaluate the evidence regarding complementary and alternative medicines (CAMs) taken orally (...) Review 2010 03 03 England Rheumatology (Oxford) 100883501 1462-0324 0 Anthocyanins 7LP2MPO46S S-Adenosylmethionine S07O44R1ZM Capsaicin AIM IM Anthocyanins therapeutic use Capsaicin therapeutic use Complementary Therapies methods Cost-Benefit Analysis Fibromyalgia therapy Humans Randomized Controlled Trials as Topic S-Adenosylmethionine therapeutic use Soybeans Treatment Outcome Bird Howard H Cade Janet J Ernst Edzard E Feinmann Jane J Fisken Margaret M Lewith George G Macfarlane Gary J GJ Moots Rob

Full Text available with Trip Pro

2010 EvidenceUpdates

97. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome (PubMed)

Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome 20418173 2010 10 05 2015 11 19 1528-8447 11 6 2010 Jun The journal of pain : official journal of the American Pain Society J Pain Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. 505-21 10.1016/j.jpain.2010.01.002 Duloxetine (DLX), milnacipran (MLN), and pregabalin (PGB) are the only drugs licensed by the US Food and Drug Administration (FDA (...) ) for fibromyalgia syndrome (FMS). Evidence on the comparative benefits and harms is still accruing. The authors searched MEDLINE, SCOPUS, Cochrane Central Register of Controlled Trials, and sought unpublished data from the databases of FDA, US National Institutes for Health, and Industry through May 2009 for randomized controlled trials. Outcomes of interest were symptom reduction (pain, fatigue, sleep disturbance, depressed mood, reduced health-related quality of life), and adverse events. 17 studies

2010 EvidenceUpdates

98. Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study (PubMed)

Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study 20191481 2010 05 12 2010 06 01 2011 12 09 2151-4658 62 5 2010 May Arthritis care & research Arthritis Care Res (Hoboken) Cognitive-behavioral therapy attenuates nociceptive responding in patients with fibromyalgia: a pilot study. 618-23 10.1002/acr.20119 To explore the possibility that cognitive-behavioral therapy (CBT) influences fibromyalgia symptoms via descending inhibition (...) of nociception, we evaluated the effects of CBT on the nociceptive flexion reflex (NFR) threshold, an objective measure of spinal nociceptive transmission. Female fibromyalgia patients (n = 32) were randomized to 6 weekly sessions of telephone-delivered CBT or usual care (UC). Assessments of the NFR threshold and clinical outcomes were conducted at baseline, week 6 (post-CBT), and week 12. From baseline to week 6, the NFR threshold increased in the CBT group and decreased in the UC group (mean +/- SD 4.4

Full Text available with Trip Pro

2010 EvidenceUpdates

99. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia (PubMed)

A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia 20156949 2010 04 02 2010 06 22 2017 02 03 0315-162X 37 4 2010 Apr The Journal of rheumatology J. Rheumatol. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia. 851-9 10.3899/jrheum.090884 This randomized, double-blind, placebo-controlled, multicenter study investigated (...) the efficacy and safety of milnacipran in the treatment of fibromyalgia (FM) in a European population. Outpatients diagnosed with FM according to 1990 American College of Rheumatology criteria (N = 884) were randomized to placebo (n = 449) or milnacipran 200 mg/day (n = 435) for 17 weeks (4-week dose escalation, 12-week stable dose, 9-day down-titration), followed by a 2-week posttreatment period. The primary efficacy criterion was a 2-measure composite responder analysis requiring patients to achieve

2010 EvidenceUpdates

100. Management of fibromyalgia syndrome in adults.

Management of fibromyalgia syndrome in adults. Management of fibromyalgia syndrome in adults. | National Guideline Clearinghouse Search Sign In Username or Email * Password * Remember Me Don't have an account? Guideline Summary NGC:007367 This guideline summary has been withdrawn from NGC. Please update your bookmarks. View all withdrawn summaries in the . About NGC Guideline Summaries NGC's guidelines summaries contain information systematically derived from original guidelines. New on NGC

2010 University of Texas at Austin School of Nursing, Family Nurse Practitioner Program